Madrigal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDGL

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. 

CEO
William J. Sibold
CEOWilliam J. Sibold
Employees
528
Employees528
Headquarters
West Conshohocken, Pennsylvania
HeadquartersWest Conshohocken, Pennsylvania
Founded
2000
Founded2000
Employees
528
Employees528

MDGL Key Statistics

Market cap
7.07B
Market cap7.07B
Price-Earnings ratio
-14.47
Price-Earnings ratio-14.47
Dividend yield
—
Dividend yield—
Average volume
348.70K
Average volume348.70K
High today
$325.00
High today$325.00
Low today
$298.00
Low today$298.00
Open price
$309.17
Open price$309.17
Volume
258.21K
Volume258.21K
52 Week high
$377.46
52 Week high$377.46
52 Week low
$189.00
52 Week low$189.00

Analyst ratings

88%

of 17 ratings
Buy
88.2%
Hold
5.9%
Sell
5.9%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.